| 000 | 01674 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513231512.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(00)83039-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEinhorn, D | |
| 245 | 0 | 0 |
_aPioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cDec 2000 |
||
| 300 |
_a1395-409 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 650 | 0 | 4 | _aThiazolidinediones |
| 700 | 1 | _aRendell, M | |
| 700 | 1 | _aRosenzweig, J | |
| 700 | 1 | _aEgan, J W | |
| 700 | 1 | _aMathisen, A L | |
| 700 | 1 | _aSchneider, R L | |
| 773 | 0 |
_tClinical therapeutics _gvol. 22 _gno. 12 _gp. 1395-409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(00)83039-8 _zAvailable from publisher's website |
| 999 |
_c11130317 _d11130317 |
||